NEW YORK, Dec. 18 — Genicon Sciences is partnering with BD Biosciences Clontech to adapt its Resonance Light Scattering signal generation and detection technology for BD's microarrays.
The agreement, announced on Tuesday, gives Genicon Sciences the right to develop, manufacture, distribute, and promote its system for specific use on the BD Atlas group of microarrays. The system includes reagents, instrumentation, and analysis software.
In addition, BD Biosciences Clontech will promote Genicon's integrated assay system.
Financial details of the deal were not disclosed.
BD Biosciences Clontech, based in Palo Alto, Calif., manufactures pre-spotted glass microarrays containing up to 3,800 human, mouse, and rat DNA oligonucleotides.
Genicon Sciences, of San Diego, is a privately held company that focuses on assay technologies and development.